Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen”

1,262 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,262 results

Large-scale testing (Phase 3)UnknownNCT01352091
What this trial is testing

Adjuvant AI Combined With Zoladex

Who this might be right for
Breast Cancer
Fudan University 670
Testing effectiveness (Phase 2)UnknownNCT01266213
What this trial is testing

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Who this might be right for
Metastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal
Samsung Medical Center 147
Not applicableStudy completedNCT02434562
What this trial is testing

Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

Who this might be right for
HypogonadismEstrogensTestosterone+1 more
Universitaire Ziekenhuizen KU Leuven 73
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Early research (Phase 1)Active Not RecruitingNCT05509790
What this trial is testing

LY3484356 in Chinese Participants With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 17
Not applicableUnknownNCT00519454
What this trial is testing

Estrogen and Gender Biased Autoimmunity

Who this might be right for
Systemic Lupus Erythematosus
The Center for Rheumatic Disease, Allergy, & Immunology 75
Testing effectiveness (Phase 2)Study completedNCT01234857
What this trial is testing

Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 115
Testing effectiveness (Phase 2)Study completedNCT00290251
What this trial is testing

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Who this might be right for
Leiomyoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Post-approval studies (Phase 4)UnknownNCT03620929
What this trial is testing

Estrogen in the Prevention of Adhesion Reformation

Who this might be right for
Asherman Syndrome
Fu Xing Hospital, Capital Medical University 186
Not applicableStudy completedNCT00608062
What this trial is testing

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

Who this might be right for
Arterial StiffeningAgingMenopause
University of Colorado, Denver 155
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT01421472
What this trial is testing

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Who this might be right for
ER Positive, Her2 Negative Breast Cancer PatientsTriple Negative Breast Cancer Patients
Merrimack Pharmaceuticals 196
Not applicableUnknownNCT06346457
What this trial is testing

Breast Cancer & Antiestrogenic Therapy & Brain

Who this might be right for
Breast Cancer FemaleHealthy FemaleMenopause+1 more
International Research Training Group 2804 180
Not applicableStudy completedNCT00115505
What this trial is testing

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast Carcinoma
Alliance for Clinical Trials in Oncology 307
Not applicableEnded earlyNCT00307775
What this trial is testing

Vaginal Estrogen for the Treatment of Faecal Incontinence in Women

Who this might be right for
Fecal Incontinence
London North West Healthcare NHS Trust 43
Large-scale testing (Phase 3)UnknownNCT00386022
What this trial is testing

The Effects of Aging and Estrogen on the Pituitary

Who this might be right for
Healthy
Massachusetts General Hospital 19
Not applicableLooking for participantsNCT07400419
What this trial is testing

Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

Who this might be right for
Muscle Mass and Strength
Massachusetts General Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07340541
What this trial is testing

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Who this might be right for
Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer+2 more
UNC Lineberger Comprehensive Cancer Center 700
Testing effectiveness (Phase 2)Study completedNCT01377324
What this trial is testing

Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites

Who this might be right for
Metastatic Breast Cancer
University Medical Center Groningen 16
Load More Results